关注
Tarlan Namvar
Tarlan Namvar
Abbott Lab
在 umaryland.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Assessment of primary care practitioners’ attitudes and interest in pharmacogenomic testing
DM Smith, T Namvar, RP Brown, TB Springfield, BN Peshkin, RJ Walsh, ...
Pharmacogenomics 21 (15), 1085-1094, 2020
312020
Addressing racial inequality and its effects on vaccination rate: A trial comparing a pharmacist and peer educational program (MOTIVATE) in diverse older adults
KM Prioli, A Akincigil, T Namvar, J Mitchell-Williams, JJ Schafer, ...
Journal of Managed Care & Specialty Pharmacy 29 (8), 970-980, 2023
52023
Evaluating Patient and Provider Preferences for a Once-Weekly Basal Insulin in Adults with Type 2 Diabetes
D Kerr, JR Rajpura, T Namvar
Patient preference and adherence, 411-424, 2024
42024
Cardiorenal care coordination: holistic patient care opportunities in the primary care setting for patients with chronic kidney disease and atherosclerotic cardiovascular disease
E Miller, D Raj, MA Cavender, S Mehanna, T Namvar, R Ochsner
Postgraduate Medicine 135 (7), 708-716, 2023
22023
Greater persistence and adherence to basal insulin therapy is associated with lower healthcare utilization and medical costs in patients with type 2 diabetes: a retrospective …
VR Aroda, N Nielsen, KK Mangla, J Multani, V Divino, T Namvar, ...
BMJ Open Diabetes Research and Care 12 (2), e003825, 2024
12024
Improving medication management by understanding patient and caregiver preferences for medication packaging
J Chou, M Lee, T Kaminsky, T Namvar, CE Cooke, NJ Brandt
The Senior Care Pharmacist 35 (10), 446-464, 2020
12020
Perspectives in Managing Kidney Disease and Atherosclerotic Cardiovascular Disease
T Namvar, MA Cavender, E Miller, S Mehanna, R Ochsner, DS Raj
Cardiorenal Medicine 14 (1), 426-436, 2024
2024
Perspectives in Managing Kidney Disease and Atherosclerotic Cardiovascular
T Namvar, MA Cavender, E Miller, S Mehanna, R Ochsner, DS Raj
2024
1001-P: Adherence and Persistence to Basal Insulin Therapy Is Associated with Decreased Health Care Utilization in Adults with Type 2 Diabetes
NF NIELSEN, VR ARODA, KK MANGLA, V DIVINO, T NAMVAR, ...
Diabetes 72 (Supplement_1), 2023
2023
816-P: Predictors of Adherence and Persistence to Basal Insulin Therapy in Adults with Type 2 Diabetes
VR ARODA, NF NIELSEN, KK MANGLA, YI WANG, T NAMVAR, ...
Diabetes 72 (Supplement_1), 2023
2023
CARDIORENAL CARE COORDINATION: ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND CHRONIC KIDNEY DISEASE MANAGEMENT FROM PATIENT AND PROVIDER PERSPECTIVES
MA Cavender, D Raj, E Miller, S Mehanna, T Namvar, R Ochsner
Journal of the American College of Cardiology 81 (8_Supplement), 539-539, 2023
2023
EE266 A Review on the Economic Evaluation of Infertility Pharmacologic Agents in North America and European Countries
T Namvar, A Molinari, M Toscani
Value in Health 25 (12), S105-S106, 2022
2022
PCR65 Evidence for a Patient-Informed Approach to Value Assessment of Major Depressive Disorder Treatments
S Nasroodin, K Nguyen, T Namvar, R Xie, R Chapman, JF Slejko, ...
Value in Health 25 (7), S553, 2022
2022
Identifying Patients’ Attitudes Toward Major Depressive Disorder Treatment Modalities
T Namvar, L Bozzi
2021 ACCP VIRTUAL Annual Meeting, 2021
2021
Pharmacogenomics Testing: Understanding Opportunities to Expand Use in Primary Care
T Namvar, DM Smith, RP Brown, B Springfield, BN Peshkin, RJ Walsh, ...
2020 ACCP VIRTUAL Annual Meeting (October 19-30), 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–15